Table 1.

Baseline characteristics of participants at study entry

	No. (%) of participants (n = 56)
Age (years) mean (SD)	50.63 (9.68)
Marital status n (%)
Married	35 (63)
Unmarried	10 (18)
Divorced	4 (7)
Separated	2 (4)
Widowed	2 (4)
Unknown	3 (5)
Children n (%)
Yes	39 (70)
No	11 (20)
Unknown	6 (11)
Employment status n (%)
Employed	30 (54)
Retired/not employed	26 (46)
Prognostic stage at diagnosis n (%)
UICC 0	1 (2)
UICC I	21 (38)
UICC II	27 (48)
UICC III	6 (11)
UICC IV	1 (2)
Primary disease n (%)
Yes	54 (96)
No	2 (4)
Surgical procedure n (%)
Breast conserving therapy	51 (91)
Mastectomy	5 (9)
Estrogen receptor positive n (%)	45 (80)
Progesterone receptor positive n (%)	44 (79)
HER2 positive n (%)	9 (16)
Comorbidities n (%)
Cardiovascular	6 (11)
Lung	5 (9)
Kidney	1 (2)
Central nervous system	2 (4)
Neoadjuvant therapy n (%)
Chemotherapy	14 (25)
None	39 (70)
Unknown	3 (5)